Company · Private
Metro International Biotech
Developing pharmaceutical-grade NAD+ precursors intended to be tested as drugs rather than supplements.
Listing
Private
Ticker
—
Headquarters
Worcester, US
Founded
2016
Technology
NAD+ precursors
Category
Longevity thesis
NAD+ biology only becomes investable when it is held to a clinical evidence standard.
Programmes
- MIB-626Phase 2
Cardiometabolic and muscle function
Reference information for research context only. It is not a rating, a valuation or investment advice. Published developments appear in the News archive.